Trajectories of Blood Pressure Control a Year After Randomization and Incident Cardiovascular Outcomes in SPRINT
Abstract BACKGROUND While studies have assessed the association between blood pressure trajectories and cardiovascular disease (CVD) outcomes using observational data, few have assessed these associations using clinical trial data. We sought to identify systolic blood pressure (SBP) trajectories and...
Gespeichert in:
Veröffentlicht in: | American journal of hypertension 2021-09, Vol.34 (9), p.973-980 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 980 |
---|---|
container_issue | 9 |
container_start_page | 973 |
container_title | American journal of hypertension |
container_volume | 34 |
creator | German, Charles A Elfassy, Tali Singleton, Matthew J Rodriguez, Carlos J Ambrosius, Walter T Yeboah, Joseph |
description | Abstract
BACKGROUND
While studies have assessed the association between blood pressure trajectories and cardiovascular disease (CVD) outcomes using observational data, few have assessed these associations using clinical trial data. We sought to identify systolic blood pressure (SBP) trajectories and to determine if these trajectory patterns carry inherent CVD risk, irrespective of baseline blood pressure.
METHODS
SBP trajectories were identified using latent class group-based modeling among a cohort of Systolic Blood Pressure Intervention Trial (SPRINT) participants by incorporating SBP measures during the first 12 months of the trial postrandomization. Cox models were used to evaluate the association between SBP trajectory with CVD and all-cause mortality.
RESULTS
Four distinct SBP trajectories were identified: “low decline” (41%), “high decline” (6%), “low stable” (48%), and “high stable” (5%). Relative to the “low decline” group, the “low stable” group was associated with a 29% increased risk of CVD (hazard ratio [HR]: 1.29, 95% confidence interval [CI]: 1.06–1.57) and the “high stable” group was associated with a 76% increased risk of all-cause mortality (HR: 1.76, 95% CI: 1.15–2.68). Relative to the “low stable” group, the “high stable” group was associated with a 54% increased risk of all-cause mortality (HR: 1.54, 95% CI: 1.05–2.28).
CONCLUSIONS
Our results demonstrate that SBP trajectory patterns are associated with important cardiovascular outcomes, irrespective of baseline blood pressure, which may help better identify individuals at risk and assist with accurate adjudication of antihypertensive therapy to reduce future events.
Graphical Abstract
Graphical Abstract |
doi_str_mv | 10.1093/ajh/hpab059 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8457432</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ajh/hpab059</oup_id><sourcerecordid>2514593347</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-1c0f5bb225bf1bea8eec39a53f90b672f2695fc3da590fdf107115cf56e96b483</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi0EotvCiTvyCSGhUDuOnfiCVFZ8rFTRqiwHTtbEGbNeJXFqJ5Xor8dolwounEajefTMjF5CXnD2ljMtzmG_O99N0DKpH5EV1xUv6rKUj8mKNVoWNVP8hJymtGeMVUrxp-REiEZxwdSKTNsIe7RziB4TDY6-70Po6HXElJaIdB3GOYaeAv2OEOmFmzHSGxi7MPh7mH0YaW7oZrS-w3Gma4idD3eQ7NJn_mqZbRiy2Y_06_XN5sv2GXnioE_4_FjPyLePH7brz8Xl1afN-uKysBUv54Jb5mTb5j9ax1uEBtEKDVI4zVpVl65UWjorOpCauc5xVnMurZMKtWqrRpyRdwfvtLQDdjYfF6E3U_QDxJ8mgDf_Tka_Mz_CnWkqWVeizILXR0EMtwum2Qw-Wex7GDEsyZSSV1ILUdUZfXNAbQwpRXQPazgzvzMyOSNzzCjTL_--7IH9E0oGXh2AsEz_Nf0CqBOdpw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2514593347</pqid></control><display><type>article</type><title>Trajectories of Blood Pressure Control a Year After Randomization and Incident Cardiovascular Outcomes in SPRINT</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>German, Charles A ; Elfassy, Tali ; Singleton, Matthew J ; Rodriguez, Carlos J ; Ambrosius, Walter T ; Yeboah, Joseph</creator><creatorcontrib>German, Charles A ; Elfassy, Tali ; Singleton, Matthew J ; Rodriguez, Carlos J ; Ambrosius, Walter T ; Yeboah, Joseph</creatorcontrib><description>Abstract
BACKGROUND
While studies have assessed the association between blood pressure trajectories and cardiovascular disease (CVD) outcomes using observational data, few have assessed these associations using clinical trial data. We sought to identify systolic blood pressure (SBP) trajectories and to determine if these trajectory patterns carry inherent CVD risk, irrespective of baseline blood pressure.
METHODS
SBP trajectories were identified using latent class group-based modeling among a cohort of Systolic Blood Pressure Intervention Trial (SPRINT) participants by incorporating SBP measures during the first 12 months of the trial postrandomization. Cox models were used to evaluate the association between SBP trajectory with CVD and all-cause mortality.
RESULTS
Four distinct SBP trajectories were identified: “low decline” (41%), “high decline” (6%), “low stable” (48%), and “high stable” (5%). Relative to the “low decline” group, the “low stable” group was associated with a 29% increased risk of CVD (hazard ratio [HR]: 1.29, 95% confidence interval [CI]: 1.06–1.57) and the “high stable” group was associated with a 76% increased risk of all-cause mortality (HR: 1.76, 95% CI: 1.15–2.68). Relative to the “low stable” group, the “high stable” group was associated with a 54% increased risk of all-cause mortality (HR: 1.54, 95% CI: 1.05–2.28).
CONCLUSIONS
Our results demonstrate that SBP trajectory patterns are associated with important cardiovascular outcomes, irrespective of baseline blood pressure, which may help better identify individuals at risk and assist with accurate adjudication of antihypertensive therapy to reduce future events.
Graphical Abstract
Graphical Abstract</description><identifier>ISSN: 0895-7061</identifier><identifier>EISSN: 1941-7225</identifier><identifier>DOI: 10.1093/ajh/hpab059</identifier><identifier>PMID: 33861306</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Cardiovascular Diseases - epidemiology ; Clinical Trials as Topic ; Editor's Choice ; Follow-Up Studies ; Humans ; Hypertension - epidemiology ; Hypertension - prevention & control ; Incidence ; Original Contributions ; Random Allocation</subject><ispartof>American journal of hypertension, 2021-09, Vol.34 (9), p.973-980</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2021</rights><rights>American Journal of Hypertension, Ltd 2021. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</rights><rights>American Journal of Hypertension, Ltd 2021. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-1c0f5bb225bf1bea8eec39a53f90b672f2695fc3da590fdf107115cf56e96b483</citedby><cites>FETCH-LOGICAL-c412t-1c0f5bb225bf1bea8eec39a53f90b672f2695fc3da590fdf107115cf56e96b483</cites><orcidid>0000-0001-5655-2769</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,1584,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33861306$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>German, Charles A</creatorcontrib><creatorcontrib>Elfassy, Tali</creatorcontrib><creatorcontrib>Singleton, Matthew J</creatorcontrib><creatorcontrib>Rodriguez, Carlos J</creatorcontrib><creatorcontrib>Ambrosius, Walter T</creatorcontrib><creatorcontrib>Yeboah, Joseph</creatorcontrib><title>Trajectories of Blood Pressure Control a Year After Randomization and Incident Cardiovascular Outcomes in SPRINT</title><title>American journal of hypertension</title><addtitle>Am J Hypertens</addtitle><description>Abstract
BACKGROUND
While studies have assessed the association between blood pressure trajectories and cardiovascular disease (CVD) outcomes using observational data, few have assessed these associations using clinical trial data. We sought to identify systolic blood pressure (SBP) trajectories and to determine if these trajectory patterns carry inherent CVD risk, irrespective of baseline blood pressure.
METHODS
SBP trajectories were identified using latent class group-based modeling among a cohort of Systolic Blood Pressure Intervention Trial (SPRINT) participants by incorporating SBP measures during the first 12 months of the trial postrandomization. Cox models were used to evaluate the association between SBP trajectory with CVD and all-cause mortality.
RESULTS
Four distinct SBP trajectories were identified: “low decline” (41%), “high decline” (6%), “low stable” (48%), and “high stable” (5%). Relative to the “low decline” group, the “low stable” group was associated with a 29% increased risk of CVD (hazard ratio [HR]: 1.29, 95% confidence interval [CI]: 1.06–1.57) and the “high stable” group was associated with a 76% increased risk of all-cause mortality (HR: 1.76, 95% CI: 1.15–2.68). Relative to the “low stable” group, the “high stable” group was associated with a 54% increased risk of all-cause mortality (HR: 1.54, 95% CI: 1.05–2.28).
CONCLUSIONS
Our results demonstrate that SBP trajectory patterns are associated with important cardiovascular outcomes, irrespective of baseline blood pressure, which may help better identify individuals at risk and assist with accurate adjudication of antihypertensive therapy to reduce future events.
Graphical Abstract
Graphical Abstract</description><subject>Cardiovascular Diseases - epidemiology</subject><subject>Clinical Trials as Topic</subject><subject>Editor's Choice</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hypertension - epidemiology</subject><subject>Hypertension - prevention & control</subject><subject>Incidence</subject><subject>Original Contributions</subject><subject>Random Allocation</subject><issn>0895-7061</issn><issn>1941-7225</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1v1DAQhi0EotvCiTvyCSGhUDuOnfiCVFZ8rFTRqiwHTtbEGbNeJXFqJ5Xor8dolwounEajefTMjF5CXnD2ljMtzmG_O99N0DKpH5EV1xUv6rKUj8mKNVoWNVP8hJymtGeMVUrxp-REiEZxwdSKTNsIe7RziB4TDY6-70Po6HXElJaIdB3GOYaeAv2OEOmFmzHSGxi7MPh7mH0YaW7oZrS-w3Gma4idD3eQ7NJn_mqZbRiy2Y_06_XN5sv2GXnioE_4_FjPyLePH7brz8Xl1afN-uKysBUv54Jb5mTb5j9ax1uEBtEKDVI4zVpVl65UWjorOpCauc5xVnMurZMKtWqrRpyRdwfvtLQDdjYfF6E3U_QDxJ8mgDf_Tka_Mz_CnWkqWVeizILXR0EMtwum2Qw-Wex7GDEsyZSSV1ILUdUZfXNAbQwpRXQPazgzvzMyOSNzzCjTL_--7IH9E0oGXh2AsEz_Nf0CqBOdpw</recordid><startdate>20210922</startdate><enddate>20210922</enddate><creator>German, Charles A</creator><creator>Elfassy, Tali</creator><creator>Singleton, Matthew J</creator><creator>Rodriguez, Carlos J</creator><creator>Ambrosius, Walter T</creator><creator>Yeboah, Joseph</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5655-2769</orcidid></search><sort><creationdate>20210922</creationdate><title>Trajectories of Blood Pressure Control a Year After Randomization and Incident Cardiovascular Outcomes in SPRINT</title><author>German, Charles A ; Elfassy, Tali ; Singleton, Matthew J ; Rodriguez, Carlos J ; Ambrosius, Walter T ; Yeboah, Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-1c0f5bb225bf1bea8eec39a53f90b672f2695fc3da590fdf107115cf56e96b483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cardiovascular Diseases - epidemiology</topic><topic>Clinical Trials as Topic</topic><topic>Editor's Choice</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hypertension - epidemiology</topic><topic>Hypertension - prevention & control</topic><topic>Incidence</topic><topic>Original Contributions</topic><topic>Random Allocation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>German, Charles A</creatorcontrib><creatorcontrib>Elfassy, Tali</creatorcontrib><creatorcontrib>Singleton, Matthew J</creatorcontrib><creatorcontrib>Rodriguez, Carlos J</creatorcontrib><creatorcontrib>Ambrosius, Walter T</creatorcontrib><creatorcontrib>Yeboah, Joseph</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>German, Charles A</au><au>Elfassy, Tali</au><au>Singleton, Matthew J</au><au>Rodriguez, Carlos J</au><au>Ambrosius, Walter T</au><au>Yeboah, Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trajectories of Blood Pressure Control a Year After Randomization and Incident Cardiovascular Outcomes in SPRINT</atitle><jtitle>American journal of hypertension</jtitle><addtitle>Am J Hypertens</addtitle><date>2021-09-22</date><risdate>2021</risdate><volume>34</volume><issue>9</issue><spage>973</spage><epage>980</epage><pages>973-980</pages><issn>0895-7061</issn><eissn>1941-7225</eissn><abstract>Abstract
BACKGROUND
While studies have assessed the association between blood pressure trajectories and cardiovascular disease (CVD) outcomes using observational data, few have assessed these associations using clinical trial data. We sought to identify systolic blood pressure (SBP) trajectories and to determine if these trajectory patterns carry inherent CVD risk, irrespective of baseline blood pressure.
METHODS
SBP trajectories were identified using latent class group-based modeling among a cohort of Systolic Blood Pressure Intervention Trial (SPRINT) participants by incorporating SBP measures during the first 12 months of the trial postrandomization. Cox models were used to evaluate the association between SBP trajectory with CVD and all-cause mortality.
RESULTS
Four distinct SBP trajectories were identified: “low decline” (41%), “high decline” (6%), “low stable” (48%), and “high stable” (5%). Relative to the “low decline” group, the “low stable” group was associated with a 29% increased risk of CVD (hazard ratio [HR]: 1.29, 95% confidence interval [CI]: 1.06–1.57) and the “high stable” group was associated with a 76% increased risk of all-cause mortality (HR: 1.76, 95% CI: 1.15–2.68). Relative to the “low stable” group, the “high stable” group was associated with a 54% increased risk of all-cause mortality (HR: 1.54, 95% CI: 1.05–2.28).
CONCLUSIONS
Our results demonstrate that SBP trajectory patterns are associated with important cardiovascular outcomes, irrespective of baseline blood pressure, which may help better identify individuals at risk and assist with accurate adjudication of antihypertensive therapy to reduce future events.
Graphical Abstract
Graphical Abstract</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>33861306</pmid><doi>10.1093/ajh/hpab059</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-5655-2769</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0895-7061 |
ispartof | American journal of hypertension, 2021-09, Vol.34 (9), p.973-980 |
issn | 0895-7061 1941-7225 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8457432 |
source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection |
subjects | Cardiovascular Diseases - epidemiology Clinical Trials as Topic Editor's Choice Follow-Up Studies Humans Hypertension - epidemiology Hypertension - prevention & control Incidence Original Contributions Random Allocation |
title | Trajectories of Blood Pressure Control a Year After Randomization and Incident Cardiovascular Outcomes in SPRINT |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T00%3A02%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trajectories%20of%20Blood%20Pressure%20Control%20a%20Year%20After%20Randomization%20and%20Incident%20Cardiovascular%20Outcomes%20in%20SPRINT&rft.jtitle=American%20journal%20of%20hypertension&rft.au=German,%20Charles%20A&rft.date=2021-09-22&rft.volume=34&rft.issue=9&rft.spage=973&rft.epage=980&rft.pages=973-980&rft.issn=0895-7061&rft.eissn=1941-7225&rft_id=info:doi/10.1093/ajh/hpab059&rft_dat=%3Cproquest_pubme%3E2514593347%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2514593347&rft_id=info:pmid/33861306&rft_oup_id=10.1093/ajh/hpab059&rfr_iscdi=true |